Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 264,712 | 209,819 | 172,879 | 144,962 | 162,186 |
| Receivables | 216,585 | 214,562 | 184,614 | 183,897 | 206,876 |
| Inventories | 195,744 | 201,175 | 205,447 | 203,188 | 189,446 |
| Other current assets | 67,360 | 62,494 | 74,492 | 77,460 | 49,792 |
| TOTAL | $744,401 | $688,050 | $637,432 | $609,507 | $608,300 |
| Non-Current Assets | |||||
| PPE Net | 231,836 | 232,990 | 234,383 | 240,334 | 245,719 |
| Intangibles | 1,278,820 | 1,296,874 | 1,315,551 | 1,329,019 | 1,346,534 |
| Other Non-Current Assets | 331,669 | 332,687 | 335,333 | 347,288 | 357,315 |
| TOTAL | $1,842,325 | $1,862,551 | $1,885,267 | $1,916,641 | $1,949,568 |
| Total Assets | $2,586,726 | $2,550,601 | $2,522,699 | $2,526,148 | $2,557,868 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 26,699 | 23,490 | 26,269 | 30,157 | 25,311 |
| Accrued Expenses | 78,376 | 72,111 | 65,363 | 62,778 | 91,454 |
| Other current liabilities | 40,097 | 40,525 | 32,608 | 34,991 | 34,216 |
| TOTAL | $163,700 | $153,278 | $140,426 | $144,545 | $175,849 |
| Non-Current Liabilities | |||||
| Long Term Debt | 200,000 | 200,000 | 260,000 | 300,000 | 346,000 |
| Other Non-Current Liabilities | 95,497 | 97,809 | 100,263 | 104,516 | 111,042 |
| TOTAL | $314,805 | $312,019 | $371,284 | $415,789 | $463,211 |
| Total Liabilities | $478,505 | $465,297 | $511,710 | $560,334 | $639,060 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 156,818 | 156,569 | 156,453 | 155,813 | 155,550 |
| Common Shares | 1,561 | 1,565 | 1,559 | 1,557 | 1,550 |
| Retained earnings | 1,144,188 | 1,145,192 | 1,106,819 | 1,082,534 | 1,066,049 |
| Other shareholders' equity | -70,580 | -66,856 | -62,344 | -64,395 | -59,880 |
| TOTAL | $2,108,221 | $2,085,304 | $2,010,989 | $1,965,814 | $1,918,808 |
| Total Liabilities And Equity | $2,586,726 | $2,550,601 | $2,522,699 | $2,526,148 | $2,557,868 |